CSIMarket
 
Transmedics Group Inc   (NASDAQ: TMDX)
 

Transmedics Group Inc's Suppliers Performance

TMDX's Supply Chain




 
TMDX Costs vs Sales of Suppliers Growth Transmedics Group Inc recorded an increase in cost of sales by 26.27 % year on year, sequentially cost of sales grew by 5.47 % in Q2.

• More on TMDX Suppliers



Transmedics Group Inc recorded increase in cost of sales by 26.27 % year on year, sequentially cost of sales grew by 5.47 % in Q2.

• More on TMDX Suppliers




Transmedics Group Inc's Comment on Supply Chain


The company depends on specific raw materials and components designed for use in the OCS, which may lack readily available substitutes. Delays, quality issues, or supplier changes could disrupt manufacturing, cause production delays, increase costs, and affect timely product delivery. Challenges in sourcing components may also impact the development of next-generation OCS products, potentially requiring product modifications that could lead to regulatory challenges, higher costs, and customer dissatisfaction. Additionally, the company's NOP relies on third-party private aircraft to transport donor organs and medical personnel. The availability and cost of these flight services are subject to risks including fuel price fluctuations, work stoppages, weather hazards, limited aircraft and qualified pilots, and market demand. Failure to secure necessary flight services could restrict NOP operations or increase costs, potentially reducing customer utilization of the company's services.

Transmedics Group Inc's Comment on Supply Chain


The company depends on specific raw materials and components designed for use in the OCS, which may lack readily available substitutes. Delays, quality issues, or supplier changes could disrupt manufacturing, cause production delays, increase costs, and affect timely product delivery. Challenges in sourcing components may also impact the development of next-generation OCS products, potentially requiring product modifications that could lead to regulatory challenges, higher costs, and customer dissatisfaction. Additionally, the company's NOP relies on third-party private aircraft to transport donor organs and medical personnel. The availability and cost of these flight services are subject to risks including fuel price fluctuations, work stoppages, weather hazards, limited aircraft and qualified pilots, and market demand. Failure to secure necessary flight services could restrict NOP operations or increase costs, potentially reducing customer utilization of the company's services.







TMDX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Transmedics Group Inc 3,362.18 668.47 153.53 898
SUBTOTAL 0.00 0.00 0.00 -


Sources: Transmedics Group Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Transmedics Group Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.